Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,483 | -21,724 | -9,927 | -15,160 | N/A |
| Depreciation Amortization | 699 | 664 | 784 | 946 | N/A |
| Accounts payable and accrued liabilities | 840 | 1,068 | 103 | -199 | N/A |
| Other Working Capital | -774 | 2,340 | -504 | -236 | N/A |
| Other Operating Activity | 3,410 | 5,952 | 636 | 3,015 | 0 |
| Operating Cash Flow | $-33,308 | $-11,700 | $-8,908 | $-11,634 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,392 | -1,397 | -59 | -550 | N/A |
| Investing Cash Flow | $-10,392 | $-1,397 | $-59 | $-550 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77,060 | 63,524 | 12,045 | 7,283 | N/A |
| Other Financing Activity | 410 | -324 | 0 | 0 | 0 |
| Financing Cash Flow | $77,470 | $63,200 | $12,045 | $7,283 | $N/A |
| Exchange Rate Effect | -48 | -18 | -1 | N/A | N/A |
| Beginning Cash Position | 57,329 | 7,244 | 4,167 | 9,068 | N/A |
| End Cash Position | 91,051 | 57,329 | 7,244 | 4,167 | N/A |
| Net Cash Flow | $33,722 | $50,085 | $3,077 | $-4,901 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,308 | -11,700 | -8,908 | -11,634 | N/A |
| Capital Expenditure | -10,392 | -1,397 | -59 | -550 | N/A |
| Free Cash Flow | -43,700 | -13,097 | -8,967 | -12,184 | 0 |